Related Experiment Videos
Relationship between CD4 count and CD4% in HIV-infected people
L M Yu1, P J Easterbrook, T Marshall
1HIV Epidemiology Unit, Chelsea and Westminster Hospital, London, UK.
International Journal of Epidemiology
|February 3, 1998
Summary
The relationship between CD4 count and CD4% is complex. Factors like gender, risk group, AIDS diagnosis, and treatments influence CD4 count, limiting its direct clinical application.
Area of Science:
- Immunology
- HIV/AIDS Research
- Clinical Epidemiology
Background:
- CD4 count and CD4% are critical markers for HIV disease progression and treatment monitoring.
- Understanding the precise relationship between these two measures is essential for accurate clinical assessment.
Purpose of the Study:
- To elucidate the relationship between absolute CD4 count and CD4% in HIV-positive individuals.
- To investigate how factors such as gender, risk group, age, AIDS diagnosis, zidovudine (ZDV) therapy, and Pneumocystis pneumonia (PCP) prophylaxis affect this relationship.
Main Methods:
- Analysis of 9203 paired serial measurements of CD4 count and CD4% from 1017 initially AIDS-free and ZDV-naive HIV-positive patients in a London cohort.
- Utilized multi-level regression on log-transformed data to model the relationship between CD4 count and CD4%.
Main Results:
- A strong linear relationship was identified between log CD4 count and log CD4% (CD4 = 5.93 * (CD4%)^1.26).
- Covariates significantly influenced the predicted CD4 count for a given CD4%. Notably, heterosexuals and injecting drug users had lower predicted CD4 counts compared to homosexual men.
- An AIDS diagnosis, ZDV therapy, and PCP prophylaxis were also associated with lower predicted CD4 counts for a given CD4%.
Conclusions:
- The relationship between CD4 count and CD4% is not straightforward and is influenced by various clinical and demographic factors.
- While the model provides a framework, wide confidence intervals and necessary adjustments for covariates limit its precise application in clinical settings.